Jie Mo
Impact in
-
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- RNA Research and Splicing
- Cancer-related gene regulation
- RNA and protein synthesis mechanisms
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
Papers in
-
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 3
- Cancer-related gene regulation 3
- Oncology 7
- Peptidase Inhibition and Analysis 3
- Co-authors
- Bixiang Zhang (12 shared papers)Jin Chen (12 shared papers)Su Chen (7 shared papers)Huifang Liang (11 shared papers)Zhibin Liao (5 shared papers)Pengcheng Li (4 shared papers)Xiaoping Chen (3 shared papers)Bixiang Zhang (5 shared papers)
In The Last Decade
Jie Mo
24 papers receiving 468 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 102
- Molecular Biology 327
- Cell Biology 52
- Immunology 50
- Oncology 60
Countries citing papers authored by Jie Mo
This map shows the geographic impact of Jie Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Mo more than expected).
Fields of papers citing papers by Jie Mo
This network shows the impact of papers produced by Jie Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Mo. The network helps show where Jie Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jie Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 148 | |
| 2 | 2022 | 87 | |
| 3 | 2020 | 45 | |
| 4 | 2024 | 32 | |
| 5 | 2023 | 23 | |
| 6 | 2019 | 22 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 13 | |
| 9 | Type-2 11β-hydroxysteroid dehydrogenase promotes the metastasis of colorectal cancer via the Fgfbp1-AKT pathway. | 2020 | 13 |
| 10 | 2023 | 12 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2024 | 9 | |
| 14 | 2024 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2023 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2014 | 3 | |
| 20 | 2015 | 3 |
About Jie Mo
Jie Mo is a scholar working on Molecular Biology, Oncology, Cancer Research, Complementary and alternative medicine and Cell Biology, having authored 26 papers that have together received 473 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Cancer-related molecular mechanisms research (3 papers), Acupuncture Treatment Research Studies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Mechanisms and Therapy (3 papers), RNA modifications and cancer (3 papers), Cancer-related gene regulation (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (102 citations), Molecular Biology (327 citations), Cell Biology (52 citations), Immunology (50 citations) and Oncology (60 citations). Jie Mo has collaborated with scholars based in China, Taiwan and Germany. Frequent co-authors include Bixiang Zhang, Jin Chen, Su Chen, Huifang Liang, Zhibin Liao, Pengcheng Li, Xiaoping Chen, Bixiang Zhang, Qiumeng Liu and Xiaoping Chen. Their work appears in journals such as Cell Death and Disease, Biomarker Research, Clinical and Translational Medicine, Oncogene and Autophagy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.